Take Three Actions Now to Zap Zika and Prevent Birth Defects

Read more

Fighting Zika, Empowering Pregnant Women

Read more

Reducing Maternal Mortality in the United States

Read more

CDC Foundation Partnership to Help Reduce Maternal Mortality in the United States

Strong, accurate data are critical for identifying opportunities for preventing deaths among mothers and designing effective interventions. A new collaboration between the CDC Foundation, the Centers for Disease Control and Prevention and the Association of Maternal and Child Health Programs will produce stronger data than ever before and foster collaboration that can lead to effective interventions. Funding for the collaboration was provided through an award agreement with Merck on behalf of its Merck for Mothers program.

Temporal Variability-Urine Phenol During Pregnancy

848
environmental health
Temporal Variability-Urine Phenol During Pregnancy
France
To study the temporal variability of phenol urinary concentrations during pregnancy, focusing on the between-day and between-trimester variability. The study will identify the efficiency of within-subject pooling of biospecimens to characterize the mean urinary levels of phenols during pregnancy.
Institut Albert Bonniot
CDC’s National Center for Environmental Health

Pregnancy and Endocrine Disruptors

846
pregnancy
Pregnancy and Endocrine Disruptors
Massachusetts, USA
United States of America
To assess the feasibility of collecting urine and blood specimens from women who enroll in the Boston University Pregnancy Study Online program and to characterize the distribution of urinary bisphenol A (BPA) and phthalate-metabolites and serum-perfluorinated chemicals in collected urine and blood specimens.
Slone Epidemiology Center at Boston University
CDC’s National Center for Environmental Health

Microbiome in Pregnancy and Infancy

834
infant child
Microbiome in Pregnancy and Infancy
Massachusetts, USA
United States of America
To characterize environmental exposures experienced by pregnant women and their infant children and their association with the developing human intestinal microbiome. Concentrations of triclosan and parabens will be measured in urines collected from pregnant women who participated in the Lifecodes study and their infants.
Brigham and Women's Hospital Div of Rheumatology, Immunology and Allergy (Partners HealthCare System, Inc.): Partner: Harvard University Medical School (Partners Healthcare System)
CDC’s National Center for Environmental Health

Child Development and Exposure to Phthalates and BPA

661
baby
Child Development and Exposure to Phthalates and B
Massachusetts, USA
United States of America
To assess the effects of exposure to phthalates and bisphenol A (BPA) on the fetal and pubertal development of children.
Harvard Medical School Channing Laboratory (National Institute of Environmental Health Sciences / National Institutes of Health and the Environmental Protection Agency); Previous Partners: University of Illinois at Urbana-Champaign; Harvard Medical School (National Institute of Environmental Health Sciences); Partners Health System
CDC’s National Center for Environmental Health

Endocrine Disruptors Exposure and Prenatal Risk

878
environmental health
Endocrine Disruptors Exposure and Prenatal Risk
Israel
To examine whether maternal exposure to endocrine disrupting chemicals (e.g., phenols, phthalates) affect maternal the ribonucleic acid profile as well as ribonucleic acid, proteins and hormonal levels and whether in-utero and early life outcomes differ between males and female twins in the same twin pair.
Sheba Medical Center and Tel Aviv University
CDC’s National Center for Environmental Health
Subscribe to Maternal and Child Health